Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from China Resources Pharmaceutical Group Ltd. ( (HK:3320) ).
China Resources Pharmaceutical Group Limited has declared a final ordinary dividend of RMB 0.122 per share for the financial year ended 31 December 2025, with shareholders able to receive it in either Hong Kong dollars or renminbi. The default payment will be HKD 0.139 per share, based on an exchange rate of RMB 1 to HKD 1.1363, reflecting the company’s continued return of capital to investors.
The company updated key timetable details, confirming shareholder approval is scheduled for 12 June 2026 and setting the ex-dividend date for 17 June 2026, with a record date of 23 June 2026. Eligible shareholders must complete currency elections by 16 July 2026, and the dividend is slated for payment on 3 August 2026, providing clarity on cash flow timing for investors and signaling stable shareholder remuneration.
More about China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Limited is a Hong Kong-listed pharmaceutical company engaged in the manufacture, distribution and sale of pharmaceutical products. The group focuses on supplying medicines and healthcare-related products to the Greater China market, leveraging its extensive distribution network and portfolio of branded and generic drugs.
YTD Price Performance: 10.79%
Average Trading Volume: 20,168,986
Technical Sentiment Signal: Sell
Current Market Cap: HK$30.97B
For detailed information about 3320 stock, go to TipRanks’ Stock Analysis page.